Spire Wealth Management Vyne Therapeutics Inc. Transaction History

Spire Wealth Management

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022
SELL
$0.5 - $1.15 $978 - $2,250
-1,957 Closed
0 $0
Q4 2021

Jan 14, 2022
BUY
$0.91 - $1.5 $1,780 - $2,935
1,957 New
1,957 $2,000
Q2 2021

Jul 26, 2021
SELL
$3.24 - $6.92 $55,345 - $118,207
-17,082 Closed
0 $0
Q1 2021

May 21, 2021
BUY
$6.34 - $12.68 $108,299 - $216,599
17,082 New
17,082 $117,000

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $170M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email